欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Neurotrichus gibbsii Cytochrome b (MT-CYB), partial CSB-YP769610NCAA
CSB-EP769610NCAA
CSB-BP769610NCAA
CSB-MP769610NCAA
CSB-EP769610NCAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Scapanus orarius Cytochrome b (MT-CYB), partial CSB-YP769611SBAZ
CSB-EP769611SBAZ
CSB-BP769611SBAZ
CSB-MP769611SBAZ
CSB-EP769611SBAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anthoceros formosae Photosystem I reaction center subunit VIII (psaI), partial CSB-YP769612ALI
CSB-EP769612ALI
CSB-BP769612ALI
CSB-MP769612ALI
CSB-EP769612ALI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anthoceros formosae 50S ribosomal protein L20, chloroplastic (rpl20) CSB-YP769613ALI
CSB-EP769613ALI
CSB-BP769613ALI
CSB-MP769613ALI
CSB-EP769613ALI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Parascalops breweri Cytochrome b (MT-CYB), partial CSB-YP769614PIAI
CSB-EP769614PIAI
CSB-BP769614PIAI
CSB-MP769614PIAI
CSB-EP769614PIAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris NAD (P)H-quinone oxidoreductase subunit I, chloroplastic (ndhI) CSB-YP769615AXO
CSB-EP769615AXO
CSB-BP769615AXO
CSB-MP769615AXO
CSB-EP769615AXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris NAD (P)H-quinone oxidoreductase subunit 5, chloroplastic (ndhF), partial CSB-YP769616AXO
CSB-EP769616AXO
CSB-BP769616AXO
CSB-MP769616AXO
CSB-EP769616AXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris 50S ribosomal protein L14, chloroplastic (rpl14) CSB-YP769617AXO
CSB-EP769617AXO
CSB-BP769617AXO
CSB-MP769617AXO
CSB-EP769617AXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris Photosystem II reaction center protein H (psbH), partial CSB-YP769618AXO1
CSB-EP769618AXO1
CSB-BP769618AXO1
CSB-MP769618AXO1
CSB-EP769618AXO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris 50S ribosomal protein L33, chloroplastic (rpl33) CSB-YP769619AXO
CSB-EP769619AXO
CSB-BP769619AXO
CSB-MP769619AXO
CSB-EP769619AXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris Chloroplast envelope membrane protein (cemA), partial CSB-YP769620AXO1
CSB-EP769620AXO1
CSB-BP769620AXO1
CSB-MP769620AXO1
CSB-EP769620AXO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris NAD (P)H-quinone oxidoreductase subunit J, chloroplastic (ndhJ) CSB-YP769621AXO
CSB-EP769621AXO
CSB-BP769621AXO
CSB-MP769621AXO
CSB-EP769621AXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris Cytochrome b6-f complex subunit 8 (petN), partial CSB-YP769622AXO
CSB-EP769622AXO
CSB-BP769622AXO
CSB-MP769622AXO
CSB-EP769622AXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris ATP synthase subunit a, chloroplastic (atpI), partial CSB-YP769623AXO1
CSB-EP769623AXO1
CSB-BP769623AXO1
CSB-MP769623AXO1
CSB-EP769623AXO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adiantum capillus-veneris Photosystem II reaction center protein K (psbK) CSB-YP769624AXO
CSB-EP769624AXO
CSB-BP769624AXO
CSB-MP769624AXO
CSB-EP769624AXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanidioschyzon merolae Photosystem II reaction center protein I (psbI), partial CSB-YP769625DZU
CSB-EP769625DZU
CSB-BP769625DZU
CSB-MP769625DZU
CSB-EP769625DZU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanidioschyzon merolae Photosystem II reaction center protein J (psbJ), partial CSB-YP769626DZU
CSB-EP769626DZU
CSB-BP769626DZU
CSB-MP769626DZU
CSB-EP769626DZU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanidioschyzon merolae Elongation factor Ts, chloroplastic (tsf) CSB-YP769627DZU
CSB-EP769627DZU
CSB-BP769627DZU
CSB-MP769627DZU
CSB-EP769627DZU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanidioschyzon merolae Cytochrome c-550 (psbV) CSB-YP769628DZU
CSB-EP769628DZU
CSB-BP769628DZU
CSB-MP769628DZU
CSB-EP769628DZU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanidioschyzon merolae 30S ribosomal protein S12, chloroplastic (rps12) CSB-YP769629DZU
CSB-EP769629DZU
CSB-BP769629DZU
CSB-MP769629DZU
CSB-EP769629DZU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×